ES437259A1 - Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental. - Google Patents

Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental.

Info

Publication number
ES437259A1
ES437259A1 ES437259A ES437259A ES437259A1 ES 437259 A1 ES437259 A1 ES 437259A1 ES 437259 A ES437259 A ES 437259A ES 437259 A ES437259 A ES 437259A ES 437259 A1 ES437259 A1 ES 437259A1
Authority
ES
Spain
Prior art keywords
carbon atoms
alkyl
phenyl
alkoxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES437259A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES437259A1 publication Critical patent/ES437259A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Fodder In General (AREA)
  • Pyridine Compounds (AREA)
ES437259A 1973-03-01 1975-04-30 Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental. Expired ES437259A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US336919A US3878225A (en) 1973-03-01 1973-03-01 Condensed pyrroles bearing an N-phenyl substituent

Publications (1)

Publication Number Publication Date
ES437259A1 true ES437259A1 (es) 1977-01-01

Family

ID=23318274

Family Applications (2)

Application Number Title Priority Date Filing Date
ES423562A Expired ES423562A1 (es) 1973-03-01 1974-02-23 Procedimiento para la preparacion de nuevos n-fenilpirro- les.
ES437259A Expired ES437259A1 (es) 1973-03-01 1975-04-30 Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES423562A Expired ES423562A1 (es) 1973-03-01 1974-02-23 Procedimiento para la preparacion de nuevos n-fenilpirro- les.

Country Status (20)

Country Link
US (1) US3878225A (es)
JP (1) JPS6139304B2 (es)
AT (1) AT332389B (es)
BE (1) BE811785A (es)
CA (1) CA1025455A (es)
CH (1) CH611605A5 (es)
CS (1) CS191225B2 (es)
DE (1) DE2407671C2 (es)
ES (2) ES423562A1 (es)
FI (1) FI61183C (es)
FR (1) FR2219790B1 (es)
GB (1) GB1457601A (es)
HU (1) HU170834B (es)
IE (1) IE38943B1 (es)
IL (1) IL44279A (es)
NL (1) NL177828C (es)
NO (1) NO142346C (es)
SE (1) SE397523B (es)
SU (1) SU610488A3 (es)
ZA (1) ZA741333B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056624A (en) * 1976-05-14 1977-11-01 American Hoechst Corporation Method of treating dermal inflammation
US4929622A (en) * 1987-09-24 1990-05-29 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-Methanopyrrolo-3-benzazocines
US5145965A (en) * 1987-09-24 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated 2,6-methanopyrrolo-3-benzazocines
US4814501A (en) * 1987-12-28 1989-03-21 Merck & Co., Inc. Process for preparing N,N-dimethyl 2-(methylthio) benzamides and analogs
WO2006041874A2 (en) * 2004-10-04 2006-04-20 Myriad Genetics, Inc. Compounds for alzheimer's disease
US7678823B2 (en) * 2004-10-04 2010-03-16 Myriad Pharmaceticals, Inc. Compounds for alzheimer's disease
US9216966B2 (en) 2004-10-04 2015-12-22 John Manfredi Compounds for Alzheimer's disease
JP2009532501A (ja) * 2006-04-04 2009-09-10 ミリアド ジェネティクス, インコーポレイテッド 疾患および障害のための化合物
MX2010000918A (es) * 2007-07-24 2010-03-15 Astellas Pharma Inc Derivado de bencimidazol.
RS54165B1 (sr) 2008-04-16 2015-12-31 Karo Bio Ab Novi ligandi za estrogenski receptor
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70880A (es) *
US3687971A (en) * 1970-06-22 1972-08-29 Merck & Co Inc 4-(pyrrolyl)-salicylic acid derivatives
GB1351754A (en) * 1970-07-02 1974-05-01 Allen & Hanburys Ltd Indenopyrrole derivatives

Also Published As

Publication number Publication date
NO740694L (no) 1974-09-03
ATA165474A (de) 1976-01-15
US3878225A (en) 1975-04-15
NL177828B (nl) 1985-07-01
NO142346B (no) 1980-04-28
CH611605A5 (es) 1979-06-15
IE38943B1 (en) 1978-07-05
AT332389B (de) 1976-09-27
HU170834B (hu) 1977-09-28
AU6618874A (en) 1975-09-04
CA1025455A (en) 1978-01-31
ES423562A1 (es) 1976-06-01
BE811785A (fr) 1974-09-02
FI61183B (fi) 1982-02-26
NL7402465A (es) 1974-09-03
DE2407671C2 (de) 1983-12-01
FI61183C (fi) 1982-06-10
FR2219790B1 (es) 1978-09-22
CS191225B2 (en) 1979-06-29
NL177828C (nl) 1985-12-02
IL44279A (en) 1977-10-31
FR2219790A1 (es) 1974-09-27
IE38943L (en) 1974-09-01
JPS6139304B2 (es) 1986-09-03
SE397523B (sv) 1977-11-07
GB1457601A (en) 1976-12-08
JPS49134671A (es) 1974-12-25
NO142346C (no) 1980-08-06
SU610488A3 (ru) 1978-06-05
IL44279A0 (en) 1974-05-16
DE2407671A1 (de) 1974-09-12
ZA741333B (en) 1975-02-26

Similar Documents

Publication Publication Date Title
AU578329B2 (en) Anti cancer treatment with porphyrins
ES423562A1 (es) Procedimiento para la preparacion de nuevos n-fenilpirro- les.
CA1273019C (en) ENKEPHALINASE INHIBITORS
MY100343A (en) Amide derivative and external medicament comprising same
MY121294A (en) Novel hexanoic acid derivatives.
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
EA199801017A1 (ru) Композиции для лечения заболеваний, опосредованных циклооксигеназой-2, способ лечения воспалительного заболевания
MD960212A (en) Acylfulvene analogs as antitumor remedy
HUP9801394A2 (hu) 6-Fenil-pirazolo[3,4-d]pirimidin-4-on-származékok és az ezeket tartalmazó gyógyszerkészítmények
JPS57197217A (en) Medicine for treating or preventing complication of diabetes or galactosemia, novel spiro-bonded pyrrolidin-2,5-dione and manufacture
YU47100A (sh) Novi derivati dihidroksiheksanoinske kiseline
AU6178198A (en) Method of treating a tumor
FR2362839A1 (fr) Derives de l'hydantoine et medicaments contenant ces substances
FI833907A0 (fi) Naftalen-anti-psoriatiska substanser
EP0724884A4 (en) INHIBITOR OF SIDE EFFECTS TO CANCER THERAPY
SE8305157L (sv) Biologiskt aktiva 2,5-piperazindionderivat, sett for framstellning derav samt farmaceutiska kompositioner innehallande desamma
ES2056983T3 (es) Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.
SE8304545L (sv) Bensamidderivat
ES550742A0 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
FR2455595A1 (fr) Derives de type bis(demethoxy-4 daunorubicine)-dihydrazone et leurs sels convenant en pharmacologie utiles comme medicaments
FR2446282A1 (fr) Phenylthiophenylpiperidines, leur preparation et leurs applications therapeutiques
GB1433934A (en) Thioureas
FR2285858A1 (fr) Nouveaux composes chimiques utiles comme medicaments anti-inflammatoires et procede pour leur obtention
GB1531091A (en) Pharmaceutical combination preparations